Nasdaq:US$14.57 (-0.43) | HKEX:HK$22.58 (-0.80) | AIM:£2.16 (-0.04)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 27 Sep 2015

ESMO 2015: Phase II trial of fruquintinib in metastatic colorectal cancer

1 items
View PDF